investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Novel therapeutic targets for CCNE1-amplified high-grade serous ovarian carcinomas
Michael Herman Chui
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michael Herman Chui
Ontario Institute for Cancer Research
Toronto, Canada
Related projects
Xiaolu Yang
Role of p53 Family Proteins in Glucose Metabolism
Ovary
Pathology
Shyam Sharan
Identification of Genetic Interactors of Brca2
Ovary
Deborah Morrison
Regulation of Ras-Dependent Signal Transduction Pathways
Ovary
Hans Schreiber
Immunology of Unique Tumor Specific Antigens
Ovary
Dana Pe'Er
Integrative Cancer Genomics: Drivers, Pathways and Drugs
Ovary
Catherine Phelan
The Mitochondrial Genome and Ovarian Cancer Risk
Ovary
Pathology
Sohrab Shah
The clonal dynamics of ovarian cancers: phylogenetic models of chemosensitivity and resistance
Ovary
Pathology
Robert Rottapel
Elucidation of the role of the RhoGEF Lfc in human epithelial tumors
Ovary
Jérôme Fortin
Genetic and functional dissection of PTEN tumor suppressor activity in high-grade ovarian serous carcinoma
Ovary